Rachel Harding

Dr. Rachel Harding is a Researcher at the Structural Genomics Consortium (SGC) affiliated with the University of Toronto. Her work focuses on understanding the molecular mechanisms underlying Huntington’s disease, particularly the role of the Huntington’s disease protein. She presented a seminar titled "Insights into the Huntington’s disease protein" on January 17, 2023, at the BBS Seminar Series hosted by McMaster University’s Department of Biochemistry and Biomedical Sciences.

Her research interests span neurodegenerative diseases, protein structure analysis, and structural genomics, aiming to advance therapeutic strategies for disorders like Huntington’s. Dr. Harding’s affiliation with the SGC highlights her involvement in collaborative, open-science initiatives focused on drug discovery and fundamental biological research.

No awards, grants, or specific lab affiliations beyond the SGC are explicitly detailed in the provided text. Her professional activities include academic seminars and likely contributions to interdisciplinary research projects.